IMAAVY
Formula & Concentration
IMAAVY- nipocalimab injection, solution, concentrate
Manufacturer
Jom Pharmaceutical Services Inc.
Indications
IMAAVY is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients 12 years of age and older who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.
Shelf Life and Storage
Store vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light until the time of use. Do not freeze. Do not shake.




